Chongqing Genrix Biopharmaceutical Co., Ltd.

Calculating rank

USPTO Granted Patents = 5

Forward Citations = 0

Loading Chart...

8 inventors (with patents filed for the assignee):

Zhigang Liu (5 out of 21 patents)

Yulan Liu (5 out of 10 patents)

Xiaobo Hao (5 out of 10 patents)

4. Junjie Hu (5 out of 6 patents)

5. Xiaowei Zhou (3 out of 3 patents)

6. Xueping Zhang (2 out of 3 patents)

7. Shunan Wan (2 out of 3 patents)

8. Jingjing Guo (2 out of 4 patents)

5 patents: Sort by Forward Citations

1. 12767702 - ANTI-VARICELLA-ZOSTER VIRUS ANTIBODY AND USE THEREOF (2026-10-20),

2. 12753227 - ANTIBODIES AGAINST HUMAN TSLP AND USE THEREOF (2026-10-06),

3. 12703758 - ANTI-CD3E/BCMA BISPECIFIC ANTIBODY AND USE THEREOF (2026-08-11),

4. 12649777 - ANTIBODY FOR TETANUS TOXIN AND USE THEREOF (2026-06-09),

5. 12559556 - BCMA x CD3 T BISPECIFIC CELL ENGAGER (2026-02-24),

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

5 Patents

#60 in Chongqing

#5,286 in China

Chongqing, China

Chongqing Genrix Biopharmaceutical Co., Ltd.

Forward Citations = 0

8 inventors:

Zhigang Liu (5 out of 21 patents)

Yulan Liu (5 out of 10 patents)

Xiaobo Hao (5 out of 10 patents)

4. Junjie Hu (5 out of 6 patents)

5. Xiaowei Zhou (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Chongqing Genrix Biopharmaceutical Co., Ltd.. Retrieved from https://idiyas.com/company/chongqing-genrix-biopharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]